{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:36:33Z","timestamp":1779316593371,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,7,1]]},"DOI":"10.1038\/sj.bmt.1702472","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:44:10Z","timestamp":1031154250000},"page":"161-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation"],"prefix":"10.1038","volume":"26","author":[{"given":"G","family":"Yanik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JE","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Ratanatharathorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RJ","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,7,17]]},"reference":[{"key":"BF1702472_CR1","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.7164\/antibiotics.40.1249","volume":"40","author":"T Kino","year":"1987","unstructured":"Kino T, Hatanaka H, Hashimoto M et al. FK-506, a novel immunosuppressant isolated from a streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics J Antibiot (Tokyo) 1987 40: 1249\u20131255","journal-title":"J Antibiot (Tokyo)"},{"key":"BF1702472_CR2","first-page":"1045","volume":"21","author":"N Yoshimura","year":"1989","unstructured":"Yoshimura N, Matsui S, Hamashima T et al. A new immunosuppressive agent, FK-506, inhibits the expression of alloantigen-activated suppressor cells as well as the induction of alloreactivity Transplant Proc 1989 21: 1045\u20131047","journal-title":"Transplant Proc"},{"key":"BF1702472_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/00007890-198902000-00035","volume":"47","author":"N Yoshimura","year":"1989","unstructured":"Yoshimura N, Matsui S, Hamashima T et al. Effect of a new immunosuppressive agent, FK-506, on human lymphocyte responses in vitro. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2 Transplantation 1989 47: 356\u2013359","journal-title":"Transplantation"},{"key":"BF1702472_CR4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4049\/jimmunol.148.4.1049","volume":"148","author":"DK Bishop","year":"1992","unstructured":"Bishop DK, Li W . Cyclosporin A and FK-506 mediate differential effects on T cell activation in vivo J Immunol 1992 148: 1049\u20131054","journal-title":"J Immunol"},{"key":"BF1702472_CR5","doi-asserted-by":"publisher","first-page":"11205","DOI":"10.1073\/pnas.92.24.11205","volume":"92","author":"KT Shaw","year":"1995","unstructured":"Shaw KT, Ho AM, Raghavan A et al. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells Proc Natl Acad Sci USA 1995 92: 11205\u201311209","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1702472_CR6","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1182\/blood.V84.8.2612.2612","volume":"84","author":"A Mouzaki","year":"1994","unstructured":"Mouzaki A, Rungger D . Properties of transcription factors regulating interleukin-2 gene transcription through the NFAT binding site in untreated or drug-treated naive and memory T-helper cells Blood 1994 84: 2612\u20132621","journal-title":"Blood"},{"key":"BF1702472_CR7","first-page":"117","volume":"183","author":"JJ Fung","year":"1996","unstructured":"Fung JJ, Eliasziw M, Todo S et al. The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation J Am Coll Surg 1996 183: 117\u2013125","journal-title":"J Am Coll Surg"},{"key":"BF1702472_CR8","first-page":"2117","volume":"28","author":"R Shapiro","year":"1996","unstructured":"Shapiro R, Jordan ML, Scantlebury VP et al. Tacrolimus in renal transplantation Transplant Proc 1996 28: 2117\u20132118","journal-title":"Transplant Proc"},{"key":"BF1702472_CR9","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1097\/00007890-199612270-00010","volume":"62","author":"R Shapiro","year":"1996","unstructured":"Shapiro R, Scantlebury VP, Jordan ML et al. Tacrolimus in pediatric renal transplantation Transplantation 1996 62: 1752\u20131758","journal-title":"Transplantation"},{"key":"BF1702472_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0003-4975(92)91371-F","volume":"54","author":"JM Armitage","year":"1992","unstructured":"Armitage JM, Kormos RL, Morita S et al. Clinical trial of FK-506 immunosuppression in adult cardiac transplantation Ann Thorac Surg 1992 54: 205\u2013211","journal-title":"Ann Thorac Surg"},{"key":"BF1702472_CR11","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1182\/blood.V87.8.3514.bloodjournal8783514","volume":"87","author":"JW Fay","year":"1996","unstructured":"Fay JW, Wingard JR, Antin JH et al. FK-506 (tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogeneic bone marrow transplantation Blood 1996 87: 3514\u20133519","journal-title":"Blood"},{"key":"BF1702472_CR12","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood.V85.12.3746.bloodjournal85123746","volume":"85","author":"RA Nash","year":"1995","unstructured":"Nash RA, Etzioni R, Storb R et al. Tacrolimus (FK-506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study Blood 1995 85: 3746\u20133753","journal-title":"Blood"},{"key":"BF1702472_CR13","first-page":"885","volume":"15","author":"A Kanamaru","year":"1995","unstructured":"Kanamaru A, Takemoto Y, Kakishita E et al. FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and\/or other immunosuppressants. Japanese FK-506 BMT Study Group Bone Marrow Transplant 1995 15: 885\u2013889","journal-title":"Bone Marrow Transplant"},{"key":"BF1702472_CR14","first-page":"561a","volume":"90","author":"AF Hiraoka","year":"1997","unstructured":"Hiraoka AF . Results of a phase III study on prophylactic use of FK506 for acute GVHD compared with cyclosporin in allogeneic bone marrow transplantation Blood 1997 90: 561a","journal-title":"Blood"},{"key":"BF1702472_CR15","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/sj.bmt.1700813","volume":"19","author":"JP Uberti","year":"1997","unstructured":"Uberti JP, Silver SM, Adams PT et al. Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies Bone Marrow Transplant 1997 19: 1233\u20131238","journal-title":"Bone Marrow Transplant"},{"key":"BF1702472_CR16","first-page":"393b (Abstr. 45","volume":"90","author":"JP Uberti","year":"1997","unstructured":"Uberti JP, Scalzo A, Hammelef K et al. Allogeneic peripheral blood stem cell transplantation for hematologic malignancy: the efficacy of tacrolimus in the prevention of acute graft-versus-host disease Blood 1997 90: 393b (Abstr. 4514)","journal-title":"Blood"},{"key":"BF1702472_CR17","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/00007890-199612270-00022","volume":"62","author":"D Przepiorka","year":"1996","unstructured":"Przepiorka D, Ippoliti C, Khouri I et al. Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus Transplantation 1996 62: 1806\u20131810","journal-title":"Transplantation"},{"key":"BF1702472_CR18","first-page":"2303","volume":"92","author":"V Ratanatharathorn","year":"1998","unstructured":"Ratanatharathorn V, Nash RA, Przepiorka D et al. Phase III study comparing methotrexate and tacrolimus (Prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation Blood 1998 92: 2303\u20132314","journal-title":"Blood"},{"key":"BF1702472_CR19","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1182\/blood.V88.9.3634.bloodjournal8893634","volume":"88","author":"RA Nash","year":"1996","unstructured":"Nash RA, Pineiro LA, Storb R et al. FK-506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors Blood 1996 88: 3634\u20133641","journal-title":"Blood"},{"key":"BF1702472_CR20","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1182\/blood.V88.11.4383.4383","volume":"88","author":"D Przepiorka","year":"1996","unstructured":"Przepiorka D, Ippoliti C, Khouri I et al. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation Blood 1996 88: 4383\u20134389","journal-title":"Blood"},{"key":"BF1702472_CR21","first-page":"25","volume":"3","author":"SM Devine","year":"1997","unstructured":"Devine SM, Geller RB, Lin LB et al. The outcome of unrelated donor marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low-dose methotrexate for graft-versus-host disease prophylaxis Biol Blood Marrow Transplant 1997 3: 25\u201333","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1702472_CR22","first-page":"561a","volume":"90","author":"RA Nash","year":"1997","unstructured":"Nash RA, Antin J, Karanes C et al. Phase III study comparing tacrolimus (FK506) with cyclosporine (CSP) for prophylaxis of acute graft-versus-host disease (GVHD) after marrow transplantation from unrelated donors Blood 1997 90: 561a","journal-title":"Blood"},{"key":"BF1702472_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1083-8791(98)50005-5","volume":"4","author":"JO Wingard","year":"1998","unstructured":"Wingard JO, Nash RA, Przepiorka D et al. Relationship of tacrolimus (Prograf, FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation Biol Blood Marrow Transplant 1998 4: 157\u2013163","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1702472_CR24","first-page":"895","volume":"15","author":"MT Koehler","year":"1995","unstructured":"Koehler MT, Howrie D, Mirro J et al. FK-506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation Bone Marrow Transplant 1995 15: 895\u2013899","journal-title":"Bone Marrow Transplant"},{"key":"BF1702472_CR25","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/sj.bmt.1701807","volume":"23","author":"D Przepiorka","year":"1999","unstructured":"Przepiorka D, Petropoulos D, Mullen CA et al. Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation Bone Marrow Transplant 1999 23: 1291\u20131296","journal-title":"Bone Marrow Transplant"},{"key":"BF1702472_CR26","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"JR Jones","year":"1997","unstructured":"Jones JR, Lee KSK, Beschorner WE et al. Veno-occlusive disease of the liver following bone marrow transplantation Transplantation 1997 44: 778\u2013783","journal-title":"Transplantation"},{"key":"BF1702472_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors Transplantation 1974 18: 295\u2013304","journal-title":"Transplantation"},{"key":"BF1702472_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long term clinicopathologic study of 20 Seattle patients Am J Med 1980 69: 204\u2013217","journal-title":"Am J Med"},{"key":"BF1702472_CR29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/00041552-199307000-00017","volume":"2","author":"J McCauley","year":"1993","unstructured":"McCauley J . The nephrotoxicity of FK506 as compared with cyclosporine Curr Opin Nephrol Hypertens 1993 2: 662\u2013669","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"BF1702472_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/ana.410350422","volume":"35","author":"EF Wijdicks","year":"1994","unstructured":"Wijdicks EF, Weisner RH, Dahlke LJ et al. FK506-induced neurotoxicity in liver transplantation Ann Neurol 1994 35: 498\u2013501","journal-title":"Ann Neurol"},{"key":"BF1702472_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00007890-199405820-00006","volume":"58","author":"AR Mueller","year":"1994","unstructured":"Mueller AR, Platz KP, Bechstein WO et al. Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506 Transplantation 1994 58: 155\u2013170","journal-title":"Transplantation"},{"key":"BF1702472_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ana.410400406","volume":"40","author":"SL Small","year":"1996","unstructured":"Small SL, Fukui MD, Bramblett GT et al. Immunosuppression-induced leukoencephlopathy from tacrolimus (FK-506) Ann Neurol 1996 40: 575\u2013580","journal-title":"Ann Neurol"},{"key":"BF1702472_CR33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/(SICI)1096-8652(199608)52:4<310::AID-AJH11>3.0.CO;2-H","volume":"52","author":"S Mach-Pascual","year":"1996","unstructured":"Mach-Pascual S, Samii K, Beris P . Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy Am J Hematol 1996 52: 310\u2013312","journal-title":"Am J Hematol"},{"key":"BF1702472_CR34","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1097\/00007890-199610270-00025","volume":"62","author":"B Kaplan","year":"1996","unstructured":"Kaplan B, Wang Z, Abecassis MM et al. Frequency of hyperkalemia in recipients of simultaneous pancreas and kidney transplants with bladder drainage Transplantation 1996 62: 1174\u20131175","journal-title":"Transplantation"},{"key":"BF1702472_CR35","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/ki.1996.417","volume":"50","author":"TF Andoh","year":"1996","unstructured":"Andoh TF, Burdmann EA, Fransechini N et al. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK-506 Kidney Int 1996 50: 1110\u20131117","journal-title":"Kidney Int"},{"key":"BF1702472_CR36","doi-asserted-by":"publisher","first-page":"746","DOI":"10.2165\/00003495-199346040-00009","volume":"46","author":"DH Peters","year":"1993","unstructured":"Peters DH, Fitton A, Plosker GL et al. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation Drugs 1993 46: 746\u2013794","journal-title":"Drugs"},{"key":"BF1702472_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0140-6736(92)92482-U","volume":"340","author":"T Ichihashi","year":"1992","unstructured":"Ichihashi T, Naoe T, Yoshida H et al. Haemolytic oraemic syndrome during FK506 therapy Lancet 1992 340: 60\u201361","journal-title":"Lancet"},{"key":"BF1702472_CR38","first-page":"715","volume":"16","author":"VS Gharpure","year":"1995","unstructured":"Gharpure VS, Devine SM, Holland HK et al. Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation Bone Marrow Transplant 1995 16: 715\u2013716","journal-title":"Bone Marrow Transplant"},{"key":"BF1702472_CR39","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood.V91.9.3503","volume":"91","author":"P Zikos","year":"1998","unstructured":"Zikos P, Van Lint MT, Frassoni F et al. Low transplant mortality in allogeneic bone marrow transplantation for acute leukemia: a randomized study of low-dose cyclosporin vs low-dose cyclosporin and low-dose methotrexate Blood 1998 91: 3503\u20133508","journal-title":"Blood"},{"key":"BF1702472_CR40","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.V73.6.1729.1729","volume":"73","author":"R Storb","year":"1989","unstructured":"Storb R, Deeg HJ, Pepe M et al. Methotrexate and cyclosporine vs cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial Blood 1989 73: 1729\u20131734","journal-title":"Blood"},{"key":"BF1702472_CR41","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1056\/NEJM198603203141201","volume":"314","author":"R Storb","year":"1986","unstructured":"Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia New Engl J Med 1986 314: 729\u2013735","journal-title":"New Engl J Med"},{"key":"BF1702472_CR42","first-page":"S57","volume":"21","author":"C Peters","year":"1998","unstructured":"Peters C, Minkov M, Gadner H et al. Proposal for standard recommendations for prophylaxis of graft-versus-host disease in children Bone Marrow Transplant 1998 21: (Suppl. 2) S57\u2013S60","journal-title":"Bone Marrow Transplant"},{"key":"BF1702472_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2141.1992.tb06399.x","volume":"80","author":"M Stockschlader","year":"1992","unstructured":"Stockschlader M, Storb R, Pepe M et al. A pilot study of low dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation Br J Haematol 1992 80: 49\u201354","journal-title":"Br J Haematol"},{"key":"BF1702472_CR44","first-page":"111","volume":"31","author":"E Gluckman","year":"1989","unstructured":"Gluckman E, Esperou H, Devergie A et al. Pediatric bone marrow transplantation for leukemia and aplastic anemia. Report of 222 cases transplanted in a single center Nouv Rev Fr Hematol 1989 31: 111\u2013114","journal-title":"Nouv Rev Fr Hematol"},{"key":"BF1702472_CR45","first-page":"449a","volume":"92","author":"V Ratanatharathorn","year":"1998","unstructured":"Ratanatharathorn V, Antin J, Karanes C et al. Relationship of tacrolimus and cyclosporine blood concentrations to the risk of acute GVHD and renal dysfunction after unrelated donor marrow transplantation Blood 1998 92: 449a","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702472","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:07:25Z","timestamp":1682035645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7,1]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,7,1]]}},"alternative-id":["BF1702472"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702472","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7,1]]},"assertion":[{"value":"10 September 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}